Page 74 - Sohini Das

Gennova's mRNA vaccine gets DCGI nod to start phase-2 and 3 trials

If things go according to plan, the vaccine would be available in the market by the end of this year, sources said

Work on non-Covid vaccines gives pharma firms an injection of hope

Approach drug regulator, seeking permission to conduct clinical trials

Zydus to soon start work on developing a vaccine for Delta variant

Also plans trials for children aged three years and above. Its needle-free injection is to be assembled in India

Astrazeneca-Sputnik jabs in combo show a better immune response: RDIF

Preliminary results from Azerbaijan trials have been announced

Johnson & Johnson seeks nod for Covid vaccine trial on adolescents

To achieve herd immunity, studies have to be done on children, pharma major says

Zydus Cadila's Covid vaccine for children above 12 years gets EUA in India

Zydus Cadila's three-dose ZyCoV-D will be administered through needle free injection system

Expert panel green signals Cadila's 3-dose DNA plasmid vaccine ZyCoV-D

DCGI nod expected soon; vaccine stable at room temperatures

J&J seeks nod to start Covid vaccine trials on 12-17 age group in India

Studies show the US company's vaccine has 66 percent efficacy against preventing moderate to severe Covid-19.

Shapoorji Mistry and Dadachanji-led Kaisha Group to enter pharma space

Plans to launch brands in antacids, analgesics, blood thinners, bump up hiring

Single dose Sputnik Light shows 93.5% efficacy against Covid, claims RDIF

Sputnik Light tested on 320,000 subjects; no jab-related deaths; no cerebral vein thrombosis and no Guillain-Barre syndrome

Fortis posts Q1 profit of Rs 430 cr on revenue growth, exceptional gain

Revenue grows 132% in Q1FY22, with that from diagnostics putting up the best show

Wockhardt signs pact with Russian co to make 620 mn Sputnik doses in 2 yrs

This is twice the amount of doses Serum Institute of will make of the Russian shot, will take total Sputnik V capacity in India to 1.7 bn doses a year

Intense price competition in US generics market hits Indian pharma

Players say low prescription, double-digit price erosion are key reasons

Non-Covid biz not back to pre-pandemic levels: Metropolis Healthcare MD

In a Q&A, Ameera Shah says, however, that the impact of the second wave on her industry segment wasn't as bad as the first

Covid-19 pandemic: Novavax shot may get nod in India even before US

SII and Novavax have now completed submission of all modules required by regulatory agencies in India, Indonesia and the Philippines for the initiation of review of the vaccine

Availability of foreign Covid vaccines to get delayed over indemnity issue

India is not keen to grant indemnity to some players as it expects local availability to improve

Mylab partners with US firm to bring more point of care Covid tests

Mylab Discovery Solutions said that some tests will be launched by the end of this month and that these could be used at hotels, malls, multiplexes, offices, airports

DRL seeks a booster from Sputnik V but hurdles in scaling up remain

Even as the company investigates complaints of malpractice in the Ukraine, hurdles in scaling up the Russian vaccine remain the bigger challenge in the near term

J&J's single-dose Covid-19 vaccine gets approval for emergency use in India

J&J did not divulge details of when the vaccine will be available in India and what kind of initial volumes can be expected

J&J seeks approval for single-dose Covid-19 vaccine in India

It is not clear whether J&J is seeking indemnity against adverse events following vaccination like its US peers